In a filing, Immix Biopharma Inc revealed its CEO and Chairman Rachman Ilya M acquired Company’s shares for reported $5050.0 on Sep 17 ’25. In the deal valued at $2.02 per share,2,500 shares were bought. As a result of this transaction, Rachman Ilya M now holds 1,140,937 shares worth roughly $2.86 million.
Then, Morris Gabriel S bought 2,600 shares, generating $5,122 in total proceeds. Upon buying the shares at $1.97, the CFO now owns 290,659 shares.
Before that, Rachman Ilya M bought 2,178 shares. Immix Biopharma Inc shares valued at $4,999 were divested by the CEO and Chairman at a price of $2.29 per share. As a result of the transaction, Rachman Ilya M now holds 1,138,437 shares, worth roughly $2.86 million.
Price Performance Review of IMMX
On Tuesday, Immix Biopharma Inc [NASDAQ:IMMX] saw its stock jump 11.80% to $2.51. Over the last five days, the stock has gained 20.10%. Immix Biopharma Inc shares have risen nearly 87.31% since the year began. Nevertheless, the stocks have risen 14.09% over the past one year. While a 52-week high of $3.20 was reached on 07/23/25, a 52-week low of $1.34 was recorded on 04/08/25.
Levels Of Support And Resistance For IMMX Stock
The 24-hour chart illustrates a support level at 2.31, which if violated will result in even more drops to 2.11. On the upside, there is a resistance level at 2.66. A further resistance level may holdings at 2.82.
How much short interest is there in Immix Biopharma Inc?
A steep rise in short interest was recorded in Immix Biopharma Inc stocks on 2025-09-15, growing by 0.33 million shares to a total of 0.45 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-15 was 0.12 million shares. There was a rise of 73.04%, which implies that there is a positive sentiment for the stock.
